INS and diabetes mellitus: However, because proinsulin/insulin ratios above 2 are rare [29,32,33,34,35,45], and less than 1% of individuals in our studies meet this criterion (Table 2), the subpopulation of diabetics that could benefit from the proposed therapy is likely few.